Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    MiNK Therapeutics Inc.

    NASDAQ: INKT · Real-Time Price · USD
    7.35
    -0.22 (-2.94%)
    At close: Jun 17, 2025, 12:26 PM

    MiNK Therapeutics Statistics

    Share Statistics

    MiNK Therapeutics has 3.99M shares outstanding. The number of shares has increased by 14.21% in one year.

    Shares Outstanding

    n/a
    		 3.99M

    Shares Change (YoY)

    n/a
    		 14.21%

    Shares Change (QoQ)

    n/a
    		 0.29%

    Owned by Institutions (%)

    n/a
    		 2.05%

    Shares Floating

    n/a
    		 990.98K

    Failed to Deliver (FTD) Shares

    n/a
    		 25

    FTD / Avg. Volume

    n/a
    		 0.46%

    Short Selling Information

    The latest short interest is 11.96K, so 0.3% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 11.96K

    Short % of Shares Out

    n/a
    		 0.3%

    Short % of Float

    n/a
    		 1.16%

    Short Ratio (days to cover)

    n/a
    		 2.85

    Valuation Ratios

    The PE ratio is -2.44 and the forward PE ratio is -3.97. MiNK Therapeutics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -2.44

    Forward PE

    n/a
    		 -3.97

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 -1.34

    P/FCF Ratio

    n/a
    		 -2.75

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for MiNK Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.72, with a Debt / Equity ratio of -0.25.

    Current Ratio

    n/a
    		 0.72

    Quick Ratio

    n/a
    		 0.72

    Debt / Equity

    n/a
    		 -0.25

    Debt / EBITDA

    n/a
    		 -0.47

    Debt / FCF

    n/a
    		 -0.52

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-468,904.43

    Employee Count

    n/a
    		 23

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -10.77B

    Effective Tax Rate

    n/a
    		 99900%

    Stock Price Statistics

    The stock price has increased by -18.68% in the last 52 weeks. The beta is 0.15, so MiNK Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.15

    52-Week Price Change

    n/a
    		 -18.68%

    50-Day Moving Average

    n/a
    		 7.45

    200-Day Moving Average

    n/a
    		 7.74

    Relative Strength Index (RSI)

    n/a
    		 53.67

    Average Volume (20 Days)

    n/a
    		 5,377

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -10.65M

    Net Income

    n/a
    		 -10.78M

    EBITDA

    n/a
    		 -10.57M

    EBIT

    n/a
    		 -10.78M

    Earnings Per Share (EPS)

    n/a
    		 -285.82
    Full Income Statement

    Balance Sheet

    The company has 4.58M in cash and 4.92M in debt, giving a net cash position of -347.57K.

    Cash & Cash Equivalents

    n/a
    		 4.58M

    Total Debt

    n/a
    		 4.92M

    Net Cash

    n/a
    		 -347.57K

    Retained Earnings

    n/a
    		 -144.18B

    Total Assets

    n/a
    		 5.72M

    Working Capital

    n/a
    		 -1.97M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.56M and capital expenditures 0, giving a free cash flow of -9.56M.

    Operating Cash Flow

    n/a
    		 -9.56M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -9.56M

    FCF Per Share

    n/a
    		 -2.53
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    INKT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for INKT is $37.5, which is 406.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $37.5

    Price Target Difference

    n/a
    		 406.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 28, 2025. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jan 28, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -41.23

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist